Not too much action today, Kymera Therapeutics drifted down slightly. We'll see where it goes next.
It looks like Kymera Therapeutics isn't currently at a very decisive point in regards to support/resistance levels. Kymera Therapeutics has been drifting up over the last few months, we'll see if it has the energy to keep moving in the right direction. KYMR might find some support at the 81.83 level, buyers might push the price back up from here. But it's not very clear what will happen.
| Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PRTA | Prothena Corporation plc | 0.89 | 1.15 | -3.29 | 4.76 | -9.01 | 1.47 | 53.32 | 28 | -0.74 | 0.96 | 6.36 | -25553.50 | -1490.98 | 0 | 150 | 11.1209 |
| VCYT | Veracyte, Inc. | 0.84 | -4.63 | -5.64 | 14.30 | 74.72 | 35.58 | 106.96 | 51 | 24.37 | 19.64 | 36.37 | -174.76 | -20810.30 | 0 | 0 | 4.97884 |
| VRNS | Varonis Systems, Inc. | 0.83 | 2.32 | 6.35 | 28.90 | 87.90 | 30.67 | -14.37 | 58 | -7.43 | -8.60 | -10.05 | -23767.54 | -6213.31 | 0 | 0 | 5.39701 |
| IDYA | IDEAYA Biosciences, Inc. | 0.74 | 4.09 | 2.48 | 28.85 | 21.61 | 8.91 | 71.76 | 53 | -8.23 | -6.51 | -7.73 | -2831.51 | -1218.40 | 0 | 0 | 11.9529 |
| DNLI | Denali Therapeutics Inc. | 0.74 | -0.58 | 1.02 | 28.25 | 31.65 | 56.45 | 73.36 | 77 | 16.94 | 27.39 | 34.77 | -222.75 | -12810.54 | 0 | 0 | 11.2371 |
| TXG | 10x Genomics, Inc. Class | 0.73 | -0.10 | 6.15 | 16.45 | 69.46 | 139.18 | 199.85 | 50 | 82.34 | 71.07 | 56.20 | -1225.00 | -15174.18 | 0 | 0 | 8.00406 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.